Activated human platelets release connective tissue growth factor

Summary

Connective tissue growth factor (CTGF) is overexpressed in wound healing, fibrosis and advanced atherosclerotic lesions. Platelets adhere to CTGF, suggesting that this protein may be involved in the formation of platelet-rich thrombi at the sites of tissue injury or atherosclerotic plaque rupture. Since platelets contain a wide array of biologically active proteins, we investigated the presence, localization and release of CTGF from these cells. For this purpose, human platelets from healthy donors were washed and stimulated with thrombin or ADP. Following incubation, proteins from unstimulated and stimulated cell lysates and the supernatants were analysed by Western blotting. The experiments showed that unstimulated platelets contain considerable amounts of CTGF, whereas no CTGF was detectable in platelet-poor plasma. To elucidate the origin of CTGF in platelets, we performed immunohistochemical analysis of human bone marrow sections. The analysis showed that although CTGF protein is widely expressed in bone marrow cells, it is not expressed by platelet-producing megakaryocytes, suggesting that CTGF presence in platelets is a result of endocytosis from extracellular environment in bone marrow. Agonist-stimulation of platelets resulted in a significant release of CTGF from the storage granules, with thrombin at 0.1 U/mL being a more potent activator than ADP at 20 µmol/L. The agonist-dependent CTGF secretion was significantly inhibited by aspirin. In conclusion, CTGF is stored in normal human platelets, and can be released upon platelet activation. Aspirin treatment prevents CTGF release, suggesting that clinical benefits of this drug may involve the inhibition of CTGF secretion.

Keywords

Platelets - connective tissue growth factor - atherosclerosis

• References

• 1 Bradham DM, Igarahashi A, Potter RL. et al.. Connective tissue growth factor: A cysteinerich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10. J Cell Biol 1991; 114: 1285-94.
• 2 Lau LF, Lam SC-T. The CCN family of angiogenic regulators: the integrin connection. Exp Cell Res 1999; 248: 44-57.
• 3 Oemar BS, Werner A, Garnier JM. et al.. Human connective tissue growth factor is expressed in advanced atherosclerotic lesions. Circulation 1997; 95: 831-9.
• 4 Ruggeri ZM. Platelets in atherothrombosis. Nature Medicine 2002; 08: 1227-34.
• 5 Jedsadayanmata A, Chen CC, Kireeva ML. et al.. Activation-dependent adhesion of human platelets to Cyr-61 and Fisp12/mouse connective tissue growth factor is mediated through integrin αIIaβ3. J Biol Chem 1999; 274: 24321-7.
• 6 Steffen CL, Ball-Mirth DK, Harding PA. et al.. Characterization of cell associated and soluble forms of connective tissue growth factor (CTGF) produced by fibroblasts cells in vitro. Growth Factors 1998; 15: 199-213.
• 7 Wang Y, Adair CD, Coe L. et al.. Activation of endothelial cells in preeclampsia: Increased neutrophil-endothelial adhesion correlates with up-regulation of adhesion molecule Pselectin in human umbilical vein endothelial cells isolated from preeclampsia. J Soc Gynecol Invest 1998; 05: 237-43.
• 8 Gnatenko DV, Dunn JJ, McCorkle SR. et al.. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003; 101: 2285-93.
• 9 Handagama P, Rappolee DA, Werb Z. et al.. Platelet alpha-granule fibrinogen, albumin, and immunoglobulin G are not synthesized by rat and mouse megakaryocytes. J Clin Invest 1990; 86: 1364-8.
• 10 Gladwin AM, Carrier MJ, Beesley JE. et al.. Identification of mRNA for PDGF-chain in human megakaryocytes isolated using a novel immunomagnetic separation method. Br J Heamatol 1990; 76: 333-9.
• 11 Ben-Ezra J, Scheibani K, Hwang DL. et al.. Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am J Pathol 1990; 137: 755-8.
• 12 Fava RA, Casey TT, Wilcox J. et al.. Synthesis of transforming growth factor-beta 1 by megakaryocytes and its localization to megakaryocyte and platelet alpha-granules. Blood 1990; 76: 1946-55.
• 13 Chan K, Spencer EM. Megakaryocytes endocytose insulin-like growth factor (IGF) I and IGF-binding protein-3: a novel mechanism directing them into alpha-granules of platelets. Endocrinology 1998; 139: 559-65.
• 14 Taylor VL, Spencer EM. Characterisation of insulin-like growth factor binding protein-3 binding to a novel receptor on human platelet membranes. J Endocrinol 2001; 168: 307-15.
• 15 Kireeva ML, Lam SCT, Lau LF. Adhesion of human umbilical vein endothelial cells to the immediate-early gene product Cyr61 is mediated through integrin αVβ3. J Biol Chem 1998; 273: 3090-6.
• 16 Nishida T, Nakanishi T, Shimo T. et al.. Demonstration of receptors specific for connective tissue growth factor on a human chondrocytic cell line (HCS-2/8). Biochem Biophys Res Commun 1998; 247: 905-9.
• 17 Segarini PR, Nesbitt JE, Li D. et al.. The low density lipoprotein receptor-related protein/alpha2-macroglobulin receptor is a receptor for connective tissue growth factor. J Biol Chem 2001; 276: 40659-67.
• 18 Gao R, Brigstock DR. Low density lipoprotein receptor-related protein (LRP) is a heparindependent adhesion receptor for connective tissue growth factor (CTGF) in rat activated hepatic stellate cells. Hepatol Res 2003; 27: 214-20.
• 19 Chambers RC, Leoni P, Blanc-Brude OP. et al.. Thrombin is a potent inducer of connective tissue growth factor production via proteolytic activation of protease-activated receptor-1. J Biol Chem 2000; 275: 35584-91.
• 20 McKenzie ME, Malinin AI, Bell CR. et al.. Aspirin inhibits surface glycoprotein IIb/IIIa, P-selectin, CD63, and CD107a receptor expression on human platelets. Blood Coagul Fibrynolysis 2003; 14: 249-53.